|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12P 21/08 | |||
| A61K 39/00 |
| (11) | Number of the document | 2252631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09763010.7 |
| Date of filing the European patent application | 2009-03-25 | |
| (97) | Date of publication of the European application | 2010-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/038171 |
| Date | 2009-03-25 |
| (87) | Number | WO 2009/151717 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 41659 P | 2008-04-02 | US |
| (72) |
JOHNSON, Leslie S., US
HUANG, Ling, US
|
| (73) |
MacroGenics, Inc.,
9640 Medical Center Drive, Rockville, MD 20850,
US
|
| (54) | BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME |
| BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME |